GlassScriptPhysician profile
Kayla Bobo
NPI 1164128849
$1,136.96
in general payments reported to CMS, 2019-2025
19 companies · $406 in 2025
The $406 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $332 · 2024: $398 · 2025: $406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,136.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $192.78 | 2023-2025 | |
| Astellas Pharma US INC | $187.61 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $144.75 | 2023-2025 | Accrufer |
| Sage Therapeutics, LLC | $112.48 | 2023-2025 | Zurzuvae |
| Exeltis, USA INC. | $100.93 | 2023-2025 | Slynd |
| Sumitomo Pharma America, INC. | $73.05 | 2023-2025 | Gemtesa, Myfembree |
| Organon LLC | $54.58 | 2024 | |
| Exact Sciences Corporation | $37.62 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $33.22 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $32.97 | 2025 | Qelbree |
| Convatec INC. | $27.22 | 2024 | |
| Coopersurgical, INC. | $22.33 | 2025 | Paragard T 380a |
| Agile Therapeutics, INC. | $21.73 | 2024 | Twirla |
| Mayne Pharma Commercial LLC | $20.57 | 2024 | |
| Hologic Sales and Service, LLC | $18.68 | 2025 | Aptima |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $15.65 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $14.87 | 2025 | |
| Abbvie INC. | $14.55 | 2025 | |
| Intuitive Surgical, INC. | $11.37 | 2023 | Da Vinci Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kayla Bobo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.